Insulin NovoRapid Versus Actrapid in Treatment of Type 1 Diabetic Patients During Daily Adjustment of Insulin Dose

NCT00145353 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG: Insulin NovoRapid versus Actrapid

Sponsor

Odense University Hospital